Actively Recruiting

Age: 20Years +
All Genders
NCT05439889

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

Led by National Taiwan University Hospital · Updated on 2024-05-17

100

Participants Needed

1

Research Sites

521 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

In recent years, the goal of stopping drug therapy, also known as treatment-free remission (TFR), is emerging as one of the management goals of chronic myeloid leukemia (CML) therapy. Because there is no available data on Asian patients with CML undergoing tyrosine kinase inhibitor discontinuation (TKI), the investigators plan to recruit chronic phase CML patients with deep treatment response and good medical compliance in Taiwan to evaluate the feasibility, safety and clinical consequences of TKI discontinuation.

CONDITIONS

Official Title

Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free Remission

Who Can Participate

Age: 20Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults aged 20 years or older with chronic phase chronic myeloid leukemia (CP-CML)
  • BCR-ABL fusion in the form of either e13a2 or e14a2 (p210)
  • No documented resistance to second-generation tyrosine kinase inhibitors (Nilotinib or Dasatinib)
  • At least 5 years of consecutive treatment with imatinib, or at least 4 years with a second-generation TKI (Nilotinib or Dasatinib)
  • Achieved MR4.5 (BCR-ABL 8 0.0032% IS) or undetectable disease for at least 2 years, documented on at least 4 separate tests performed 3 months apart
  • Access to a reliable qPCR-based BCR-ABL test sensitive to at least MR4.5
Not Eligible

You will not qualify if you...

  • Deemed ineligible by the study investigator after evaluation
  • No intention to participate in the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

National Taiwan University Hospital

Taipei, Taiwan, 10002

Actively Recruiting

Loading map...

Research Team

W

Wen-Chien Chou, MD. PhD.

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here